Skip to main content
Log in

In vitro evidence of drug action in aplastic anemia

  • Leading Article
  • Published:
Blut Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Alter BP, Potter NU, Li FP (1978) Classification and aetiology of the aplastic anaemias. Clin Haematol 7: 431–465

    Google Scholar 

  2. Anderson MJ (1982) The emerging story of a human parvovirus-like agent. J Hyg Camb 89: 1–8

    Google Scholar 

  3. Anderson MJ, Davis LR, Jones SE, Pattison JR, Sergeant GR (1982) The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg Camb 88: 309–324

    Google Scholar 

  4. Appelbaum R, Ferer A (1981) The pathogenesis of aplastic anemia. Semin Hematol 18: 241–257

    Google Scholar 

  5. Bacigalupo A, Podesta M, Van Lint MT, Vimercati R, Cerri R, Rossi E, Risso M, Carella A, Santini G, Damasio E, Giordano D, Marmont AM (1981) Severe aplastic anaemia: correlation of in vitro tests with clinical response to immunosuppression in 20 patients. Br J Haematol 47: 423–433

    Google Scholar 

  6. Barrett AJ, Faille A, Balitrand N, Ketels F, Najean Y (1979) Bone marrow culture in aplastic anaemia. J Clin Pathol 32: 660–665

    Google Scholar 

  7. Benestad HB (1974) Aplastic anaemia: considerations on the pathogenesis. Acta Med Scand 196: 255–262

    Google Scholar 

  8. Boggs DR, Boggs SS (1976) The pathogenesis of aplastic anemia: a defective pluripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication. Blood 48: 71–76

    Google Scholar 

  9. Boggs DR, Boggs SS (1978) Possible pathogenic mechanisms in aplastic anemia. Transplant Proc 10: 125–130

    Google Scholar 

  10. Camitta BM, Storb R, Thomas ED (1982) Aplastic anemia. Pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 645–652

    Google Scholar 

  11. Cline MJ, Golde DW (1978) Immune suppression of hematopoiesis. Am J Med 64: 301–310

    Google Scholar 

  12. Cline MJ, Golde DW (1979) Cellular interactions in haematopoiesis. Nature 227: 177–181

    Google Scholar 

  13. Cossart YE, Cant B, Field AM, Widdows D (1975) Parvovirus-like particles in human sera. Lancet 1: 72–73

    Google Scholar 

  14. Cunningham JL, Leyland MJ, Delamore IW, Price Evans DA (1974) Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia. Br Med J 3: 313–317

    Google Scholar 

  15. Dexter TM, Schofield R, Hendry J, Testa NG (1979) Congenital and induced defects in haemopoietic environments, stem cell proliferation and differentiation. In: Heimpel H, Gordon-Smith EC, Heit W, Kubanek B (eds) Aplastic anemia: pathophysiology and approaches to therapy. Springer, Berlin, pp 73–78

    Google Scholar 

  16. Editorial (1976) Mechanisms in aplastic anaemia. Lancet 2: 1179–1181

    Google Scholar 

  17. Editorial (1977) Aplastic anaemia: Seed or soil? Lancet 2: 748–750

    Google Scholar 

  18. Fitchen JH, Cline MJ (1978) Recent developments in understanding the pathogenesis of aplastic anemia. Am J Hematol 5: 365–372

    Google Scholar 

  19. Firkin FC, Moore MAS (1977) Atypical phenylbutazone sensitivity of marrow colony forming units in phenylbutazone-induced asplast anemia. In: Hibino S, Takaku F, Shahidi NT (eds) Aplastic anemia. University Park Press, Baltimore London Tokyo, pp 335–342

    Google Scholar 

  20. Gurney CW, Lyon JW, Simmons EL, Gaston EO, Malcolm BA (1979) Treatment of Strontium-89-induced hypoplastic anemia in mice by intraperitoneal implants of spleen slices. In: Baum SJ, Ledney GD (eds) Experimental hematology today 1979. Springer, New York Heidelberg Berlin, pp 105–110

    Google Scholar 

  21. Haak HL (1980) Experimental drug-induced aplastic anaemia. Clin Haematol 9: 621–639

    Google Scholar 

  22. Hara H, Kai S, Fushimi M, Taniwaki S, Okamoto T, Ohe Y, Fujita S, Noguchi K, Senba M, Hamano T, Kanamaru A, Nagai K (1980) Pluripotent hemopoietic precursors in vitro (CFUMIX) in aplastic anemia. Exp Hematol 8: 1165–1171

    Google Scholar 

  23. Heimpel H, Heit W (1980) Drug-induced aplastic anaemia: clinical aspects. Clin Haematol 9: 641–662

    Google Scholar 

  24. Heit W, Kern P, Heimpel H, Kubanek B (1977) Granulocytic colony forming cells in vitro: I. Patients with drug induced agranulocytosis. Blut 34: 403–405

    Google Scholar 

  25. Hinterberger W, Muhar U, Müller R, Jürgenssen O-A, Kabrna E, Paukovits WR (1981) Coexisting suppressor cells for myeloid colony formation in the bone marrow of patients with aplastic anaemia. Scand J Haematol 26: 345–350

    Google Scholar 

  26. Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR (1977) Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med 296: 10–13

    Google Scholar 

  27. Howell A, Andrews TM, Watts RWE (1975a) Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced asplastic anaemia. Lancet 1: 65–69

    Google Scholar 

  28. Howell A, Gumpel JM, Watts RWE (1975b) Depression of bone marrow colony formation in gold-induced neutropenia. Br Med J 1: 432–434

    Google Scholar 

  29. Kelton JG, Huang AT, Mold N, Logue G, Rosse WF (1979) The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med 301: 621–624

    Google Scholar 

  30. Kern P, Heimpel H, Heit W, Kubanek B (1975) Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 1: 1190

    Google Scholar 

  31. Kern P, Heimpel H, Heit W, Kubanek B (1977) Granulocytic progenitor cells in aplastic anaemia. Br J Haematol 35: 613–623

    Google Scholar 

  32. Klassen LW, Birks J, Allen E, Gurney CW (1972) Experimental medullary aplasia. J Lab Clin Med 80: 8–17

    Google Scholar 

  33. Knospe WH, Crosby WH (1971) Aplastic anaemia: a disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure? Lancet 1: 20–22

    Google Scholar 

  34. Levere RD, Ibraham NG (1982) The bone marrow as a metabolic organ. Am J Med 73: 615–616

    Google Scholar 

  35. Lind DE, Levi JA, Vincent PC (1973) Amodiaquine-induced agranulocytosis: Toxic effect of amodiaquine in bone marrow cultures in vitro. Br J Med 1: 458–460

    Google Scholar 

  36. Morley A, Blake J (1974) An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood 44: 49–56

    Google Scholar 

  37. Morley A, Blake J (1974) Haemopoietic precursor cells in experimental hypoplastic marrow failure. Aust J Exp Biol Med Sci 52: 909–914

    Google Scholar 

  38. Morley A, Trainor K, Blake J (1975) A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45: 681–687

    Google Scholar 

  39. Morley A, Trainor K, Remes J (1976) Residual marrow damage: Possible explanation for idiosyncrasy to chloramphenicol. Br J Haematol 32: 525–531

    Google Scholar 

  40. Morley A, Trainor K, Seshadri R, Sorrell J (1978) Is aplastic anaemia due to abnormality of D.N.A.? Lancet 2: 9–11

    Google Scholar 

  41. Morris TCM, Vincent PC, Young GAR, Sutherland R, Forrest P, Isbister JP (1984) CFU-C inhibitors in aplastic anaemia. Blut 48: 1–14

    Google Scholar 

  42. Mortimer P (1983) Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol 36: 445–448

    Google Scholar 

  43. Nagao T, Mauer AM (1969) Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med 281: 7–11

    Google Scholar 

  44. Nara N, Bessho M, Hirashima K, Momoi H (1982) Effects of Chloramphenicol on hematopoietic inductive microenvironment. Exp Haematol 10: 20–25

    Google Scholar 

  45. Nieweg HO (1974) Aplastic anemia (panmyelopathy) In: Girdwood RH (ed) Blood disorders due to drugs and other agents. Excerpta Med, Amsterdam, pp 83–106

    Google Scholar 

  46. Pisciotta AV (1973) Immune and toxic mechanisms in drug-induced agranulocytosis. Semin Hematol 10: 279–310

    Google Scholar 

  47. Ratzan RJ, Moore MAS, Yunis AA (1974) Effect of Chloramphenicol and Thiamphenicol on the in vitro colony-forming cell. Blood 43: 363–369

    Google Scholar 

  48. Samson JP, Hulstaert CE, Molenaar I, Nieweg HO (1972) Fine structure of the bone marrow sinusoidal wall in idiopathic and drug-induced panmyelopathy. Acta Haematol 48: 218–226

    Google Scholar 

  49. Schultz DR, Walling JS, Yunis AA (1979) Evidence for an immune mechanism in chloramphenicol-induced aplastic anemia. Clin Res 27: 464A

  50. Seed TM, Cullen SM, Kaspar LV, Tolle DV, Fritz TE (1980) Hemopathologic consequences of protracted gamma irradiation: alterations in granulocyte reserves and granulocyte mobilization. Blood 56: 42–51

    Google Scholar 

  51. Silver BJ, Zuckerman KS (1980) Aplastic anemia. Recent advances in pathogenesis and treatment. Med Clin N Am 64: 607–629

    Google Scholar 

  52. Singer JW, Brown JE (1978) In vitro marrow culture techniques in aplastic anaemia and related disorders. Clin Haematol 7: 487–499

    Google Scholar 

  53. Snyder R, Lee EW, Kocsis JJ, Witmer CM (1977) Bone marrow depressant and leukemogenic actions of benzene. Life Sciences 21: 1709–1722

    Google Scholar 

  54. Speck B, Gluckman E, Haak HL, Van Rood JJ (1978) Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol 7: 611–621

    Google Scholar 

  55. Sutherland R, Vincent PC, Raik E, Burgess K (1977) Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. Br Med J 1: 605–607

    Google Scholar 

  56. Trainor KJ, Seshadri RS, Morley AA (1979) Residual marrow injury following cytotoxic drugs. Leuk Res 3: 205–210

    Google Scholar 

  57. Tso SC, Chan TK, Todd D (1977) Aplastic anaemia: A study of prognosis and the effect of androgen therapy. Q J Med 46: 513–529

    Google Scholar 

  58. Vincent PC, de Gruchy GC (1967) Complications and treatment of acquired aplastic anaemia. Br J Haematol 13: 977–999

    Google Scholar 

  59. Vincent PC (1982) Haemopoietic inhibitors in aplastic anaemia — a review. Pathology 14: 25–29

    Google Scholar 

  60. Webley M, Coomes EN (1978) Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold? Br J Med 2: 91

    Google Scholar 

  61. Williams DM, Lynch RE, Cartwright GE (1973) Drug-induced aplastic anemia. Semin Hematol 10: 195–223

    Google Scholar 

  62. Young GAR, Vincent PC (1980) Drug-induced agranulocytosis. Clin Haematol 9: 483–504

    Google Scholar 

  63. Young GAR, Forrest P, Deveridge SF, Gates RB, Vincent PC (1982) Mebhydrolin induced agranulocytosis. Aust NZ J Med 12: 173–176

    Google Scholar 

  64. Yunis AA (1973) Chloramphenicol-induced bone marrow suppression. Semin Hematol 10: 225–234

    Google Scholar 

  65. Yunis AA (1974) Chloramphenicol toxicity. In: Girdwood RH (ed) Blood disorders due to drugs and other agents. Excerpta Med, Amsterdam, pp 107–126

    Google Scholar 

  66. Yunis AA, Adamson JW (1977) Differential in vitro sensitivity of marrow erythroid and granulocytic colony forming cells to chloramphenicol. Am J Hematol 2: 335–363

    Google Scholar 

  67. Yunis AA, Miller AM, Salem Z, Arimura GK (1980) Chloramphenicol toxicity: Pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Clin Toxicol 17: 359–373

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vincent, P.C. In vitro evidence of drug action in aplastic anemia. Blut 49, 3–12 (1984). https://doi.org/10.1007/BF00320378

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320378

Key words

Navigation